Hepatitis C Treatment

With treatment, hepatitis C is curable. Recently, the treatment of hepatitis C has been revolutionized by the U.S. Food and Drug Administration’s approval of two new drugs for the treatment of the hepatitis C virus (HCV). This marks the first major breakthrough in the advance in HCV treatment in the last decade. With these new treatments, physicians expect that the cure rate for HCV will rise from 40 percent to approximately 90 percent or higher, especially for newly diagnosed or treatment naïve patients (patients who have never been treated before for HCV).

At Mount Sinai, we were proud to have played a major role in the approval of this new class of drugs, known as protease inhibitors. And today we remain committed to finding new drugs that will improve the cure rate in more patients with HCV.

Contact Us

5 East 98th Street, 11th Floor
New York, NY 10029
Tel: 212-241-7270

Chelsea Office
275 Seventh Avenue, 12th Floor
New York, NY 10001
Tel: 212-604-1710

Chinatown Office
168 Centre Street, Floor 3M
New York, NY 10013
Tel: 212-731-3610

Queens Office
82-11 37th Avenue, 4th Floor
Jackson Heights, NY 11372
Tel: 646-747-8091

Related Resource

Adult Liver Transplantation